equity research report 1999 equitynet terry l stein analyst december 7 close as of 6 djia 11225 01 s&p 500 1423 34 nasdaq composite 3546 russell 2000 465 75 date dec shares outstanding 35 0 m eps c p e stock price 4 13 estimated float 10 1998a 29 12 mo range 69 81 recommendation buy 1999e 20 industry sector medical device 18 target us 66 2000e 30 day avg daily vol 25 000 est 5 yr growth 33 2001e 20x basis for vasogen is focused on large and growing segments the healthcare market offers investor an excellent opportunity to participate in this company has assembled a capable experienced management team with expertise guide s development programs execute its business strategy classification will allow bring products significantly faster than traditional pharmaceutical based alternatives strong product pipeline support long term several
